Valuation: Assertio Holdings

Market Cap 15Cr 13Cr 13Cr 11Cr 22Cr 1.46TCr 22Cr 152.4Cr 59Cr 746.31Cr 57Cr 56Cr 2.4TCr P/E 2024
-3.79x
P/E 2025 -1.91x
Enterprise Value 13Cr 11Cr 11Cr 9.73Cr 18Cr 1.24TCr 19Cr 129.17Cr 50Cr 632.53Cr 48Cr 47Cr 2.03TCr EV / Sales 2024
0.19x
EV / Sales 2025 0.3x
Free-Float
99.05%
Yield 2024 *
-
Yield 2025 -
1 day+0.09%
6 months+22.33%
Current year+159.10%
Current year 9.11
Extreme 9.11
23.5
1 year 8.61
Extreme 8.61
23.5
3 years 7.71
Extreme 7.705496
39
5 years 7.71
Extreme 7.705496
120.15
10 years 7.71
Extreme 7.705496
1,590
Director TitleAgeSince
Director/Board Member 26 16/06/2026
Director/Board Member - 16/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
13/05/26 Don

Chairman

-13,332 0.2069%
05/05/26 Free

Chairman

4,851 0.0753%
05/05/26 Free

Director

4,851 0.0753%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-.--%+72.26%-35.26% 15Cr
-0.61%-3.43%+36.07%+117.61% 1,01900Cr
-1.02%-5.60%+35.72%+64.82% 62TCr
+1.11%-0.58%+12.36%+78.27% 46TCr
+0.34%-3.01%+61.79%+41.79% 36TCr
-0.95%-4.05%+20.54%+40.33% 33TCr
-1.46%-2.89%+10.57%+26.54% 27TCr
-1.35%-5.43%-6.17%+8.82% 24TCr
-1.04%-2.79%+35.30%+54.42% 22TCr
-1.87%-4.10%+28.44%+97.54% 18TCr
Average -0.68%-3.02%+30.69%+49.49% 36.97TCr
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2024 2025
Net sales 12Cr 11Cr 10Cr 9.45Cr 18Cr 1.2TCr 18Cr 125.41Cr 49Cr 614.11Cr 47Cr 46Cr 1.97TCr 12Cr 11Cr 9.84Cr 8.97Cr 17Cr 1.14TCr 17Cr 119.14Cr 46Cr 583.41Cr 45Cr 44Cr 1.87TCr
Net income -2.16Cr -1.92Cr -1.79Cr -1.63Cr -3.08Cr -207.46Cr -3.11Cr -22Cr -8.39Cr -106.06Cr -8.1Cr -7.93Cr -340.38Cr -3.04Cr -2.7Cr -2.52Cr -2.3Cr -4.33Cr -292Cr -4.37Cr -30Cr -12Cr -149.28Cr -11Cr -11Cr -479.08Cr
Net Debt -5.98Cr -5.31Cr -4.96Cr -4.52Cr -8.52Cr -574.76Cr -8.6Cr -60Cr -23Cr -293.82Cr -22Cr -22Cr -942.99Cr -2.32Cr -2.06Cr -1.92Cr -1.75Cr -3.3Cr -222.57Cr -3.33Cr -23Cr -9Cr -113.78Cr -8.69Cr -8.5Cr -365.16Cr
Logo Assertio Holdings
Assertio Holdings Inc is a United States-based commercial pharmaceutical company. The Company focused on the marketing and distribution of branded prescription medicines across several therapeutic categories. It maintains a portfolio that includes treatments for neurology disorders, inflammatory conditions, pain management, and oncology. Its activities involve acquiring, licensing, and integrating approved pharmaceutical products, followed by commercialization within the healthcare market. Its operating approach centers on identifying products that have established regulatory clearance and advancing their reach through targeted sales, medical education, and market access efforts. It manages product lifecycles through activities such as labeling updates, supply coordination, and engagement with healthcare professionals and payers.
Employees
53
  1. Stock Market
  2. Stocks
  3. ASRT Stock